Atlas Trials

Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

Clinical trial NCT04173832 · UNKNOWN

Trial details

NCT number
NCT04173832
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
L-DOPA-Induced Dyskinesia
Start date
2020-01-01
Primary completion
2020-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.